Alzamend Neuro Partners With Massachusetts General Hospital for a Phase II Clinical Trial of Al001, a Next-Generation Lithium Therapeutic Drug Candidate, Involving Patients With Alzheimer’s Disease
Alzamend Neuro已与马萨诸塞州总医院合作进行第II期临床试验，试验药物Al001是下一代锂疗法药物候选，涉及阿尔茨海默病患者。